journal article·2018-09

Uniform Core–Shell Nanoparticles with Thiolated Hyaluronic Acid Coating to Enhance Oral Delivery of Insulin

Houkuan Tian, Zhiyu He, Chengxin Sun, Chengbiao Yang, Pengfei Zhao, Lixin Liu, Kam W. Leong, Hai‐Quan Mao, Zhijia Liu, Yongming Chen

Advanced Healthcare Materials· Volume 7· Issue 17
Publisher page

Abstract

Abstract Oral delivery of protein drugs is an attractive route of administration due to its convenience for repeated dosing and good patient compliance. However, currently oral protein therapeutics show very low bioavailability mainly due to the existence of hostile gastrointestinal (GI) environments, including mucus layers and intestinal epithelial barriers. Herein, using insulin as a model protein therapeutic, the core–shell nanoparticles with thiolated hyaluronic acid (HA‐SH) coating (NPHA‐SH) are produced utilizing a two‐step flash nanocomplexation process to enhance oral delivery efficiency of insulin. A positively charged nanoparticle core is first generated by electrostatic complexation between insulin and N‐(2‐hydroxypropyl)‐3‐trimethyl ammonium chloride modified chitosan (HTCC), followed by surface coating with HA‐SH. The optimized NPHA‐SH shows an average size of 100 nm with high encapsulation efficiency (91.1%) and loading capacity (38%). In vitro and ex vivo results confirm that NPHA‐SH shows high mucus‐penetration ability, improved intestinal retention and transepithelial transport property due to its thiolated surface and the ability of HA‐SH coating to dissociate from the nanoparticle surface when across the mucosal layer. Oral administration of NPHA‐SH to Type 1 diabetic rats yields high efficacy and an average relative bioavailability of 11.3%. These results demonstrate that the HA‐SH coated core–shell nanoparticles are a promising oral delivery vehicle for protein therapeutics.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Drug Solubulity and Delivery Systems · Advancements in Transdermal Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Materials Science and Engineering Center for Functional Biomaterials Key Laboratory for Polymeric Composite and Functional Materials of Ministry of Education Sun Yat‐sen University Guangzhou 510275 China

Department of Biomedical Engineering Columbia University New York NY 10027 USA

Institute for Nano BioTechnology and Department of Materials Science and Engineering Johns Hopkins University Baltimore MD 21218 USA

Department of Biomedical Engineering and Translational Tissue Engineering Center Johns Hopkins University School of Medicine Baltimore MD 21287 USA

Funding

Guangdong Innovative and Entrepreneurial Research Team Program · Natural Science Foundation of Guangdong Province · National Natural Science Foundation of China

References (41)

Show source-provided references
1. 10.1016/j.ijpharm.2014.10.05910.1016/j.ijpharm.2014.10.059 ↗
2. 10.1016/j.biomaterials.2010.01.04210.1016/j.biomaterials.2010.01.042 ↗
3. 10.1002/adfm.20150500010.1002/adfm.201505000 ↗
4. 10.1021/acsami.5b0355510.1021/acsami.5b03555 ↗
5. 10.1111/jphp.1285210.1111/jphp.12852 ↗
6. 10.1002/adfm.20150525210.1002/adfm.201505252 ↗
7. 10.1016/j.biomaterials.2011.08.08710.1016/j.biomaterials.2011.08.087 ↗
8. 10.1016/j.ijpharm.2005.01.01810.1016/j.ijpharm.2005.01.018 ↗
9. 10.1517/17425247.2015.101817510.1517/17425247.2015.1018175 ↗
10. 10.1016/j.biomaterials.2016.06.05910.1016/j.biomaterials.2016.06.059 ↗
11. 10.1126/scitranslmed.300704910.1126/scitranslmed.3007049 ↗
12. 10.1111/j.1463-1326.2009.01150.x10.1111/j.1463-1326.2009.01150.x ↗
13. 10.1016/j.addr.2011.12.00910.1016/j.addr.2011.12.009 ↗
14. 10.1021/acsnano.5b0002810.1021/acsnano.5b00028 ↗
15. 10.1021/acsami.6b0818310.1021/acsami.6b08183 ↗
16. 10.1021/acsnano.5b0387610.1021/acsnano.5b03876 ↗
17. 10.1016/j.biomaterials.2009.06.05510.1016/j.biomaterials.2009.06.055 ↗
18. 10.1016/S0169-409X(01)00180-610.1016/S0169-409X(01)00180-6 ↗
19. 10.1021/acsami.7b1652410.1021/acsami.7b16524 ↗
20. 10.1021/acs.nanolett.6b0325110.1021/acs.nanolett.6b03251 ↗
21. 10.1021/nn501371n10.1021/nn501371n ↗
22. 10.1016/j.addr.2011.04.00510.1016/j.addr.2011.04.005 ↗
23. 10.1016/j.ces.2014.08.01610.1016/j.ces.2014.08.016 ↗
24. 10.1016/j.biomaterials.2017.03.02810.1016/j.biomaterials.2017.03.028 ↗
25. 10.1039/C7NR08047F10.1039/C7NR08047F ↗
26. 10.1016/j.biomaterials.2012.09.08210.1016/j.biomaterials.2012.09.082 ↗
27. 10.1039/C3PY01083J10.1039/C3PY01083J ↗
28. 10.1016/S0928-0987(02)00025-810.1016/S0928-0987(02)00025-8 ↗
29. 10.1211/jpp.60.3.300110.1211/jpp.60.3.3001 ↗
30. 10.1016/j.ijpharm.2012.06.05410.1016/j.ijpharm.2012.06.054 ↗
31. 10.1021/bm201077410.1021/bm2010774 ↗
32. 10.1242/jcs.110.14.160310.1242/jcs.110.14.1603 ↗
33. 10.1152/ajpgi.2001.280.5.G92210.1152/ajpgi.2001.280.5.G922 ↗
34. 10.1016/j.jconrel.2015.12.00810.1016/j.jconrel.2015.12.008 ↗
35. 10.1002/adfm.20100101410.1002/adfm.201001014 ↗
36. 10.1016/j.biomaterials.2006.12.02410.1016/j.biomaterials.2006.12.024 ↗
37. 10.1002/adfm.20140355010.1002/adfm.201403550 ↗
38. 10.1016/j.carbpol.2015.05.01410.1016/j.carbpol.2015.05.014 ↗
39. 10.1021/acs.molpharmaceut.6b0018810.1021/acs.molpharmaceut.6b00188 ↗
40. 10.1016/0003-2697(85)90442-710.1016/0003-2697(85)90442-7 ↗
41. 10.1021/mp300649z10.1021/mp300649z ↗